Cargando…
Malignancy after lung transplantation
Lung transplantation is an established therapeutic option for selected patients with advanced lung diseases. As early outcomes after lung transplantation have improved, chronic medical illnesses have emerged as significant obstacles to long-term survival. Among them is post-transplant malignancy, cu...
Autores principales: | Shtraichman, Osnat, Ahya, Vivek N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186714/ https://www.ncbi.nlm.nih.gov/pubmed/32355860 http://dx.doi.org/10.21037/atm.2020.02.126 |
Ejemplares similares
-
Preface: strategies to achieve long-term success of lung transplantation
por: Sato, Masaaki, et al.
Publicado: (2020) -
Antibody-mediated rejection after lung transplantation
por: Bery, Amit I., et al.
Publicado: (2020) -
Surveillance for acute cellular rejection after lung transplantation
por: Greer, Mark, et al.
Publicado: (2020) -
Immunosuppressive strategies in lung transplantation
por: Chung, Paul A., et al.
Publicado: (2020) -
Bronchiolitis obliterans syndrome and restrictive allograft syndrome after lung transplantation: why are there two distinct forms of chronic lung allograft dysfunction?
por: Sato, Masaaki
Publicado: (2020)